295 related articles for article (PubMed ID: 28271680)
21. Spatial spectral imaging as an adjunct to the Bethesda classification of thyroid fine-needle aspiration specimens.
Hahn LD; Hoyt C; Rimm DL; Theoharis C
Cancer Cytopathol; 2013 Mar; 121(3):162-7. PubMed ID: 22833451
[TBL] [Abstract][Full Text] [Related]
22. TROP-2 expression in papillary thyroid carcinoma: Potential Diagnostic Utility.
Simms A; Jacob RP; Cohen C; Siddiqui MT
Diagn Cytopathol; 2016 Jan; 44(1):26-31. PubMed ID: 26481593
[TBL] [Abstract][Full Text] [Related]
23. BRAFV600E mutation and X-linked inhibitor of apoptosis expression in papillary thyroid carcinoma.
Gu LQ; Li FY; Zhao L; Liu Y; Zang XX; Wang TX; Chen HP; Ning G; Zhao YJ
Thyroid; 2009 Apr; 19(4):347-54. PubMed ID: 19355825
[TBL] [Abstract][Full Text] [Related]
24. Biomarker Discovery for Early Diagnosis of Papillary Thyroid Carcinoma Using High-Throughput Enhanced Quantitative Plasma Proteomics.
Lu H; Pan Y; Ruan Y; Zhu C; Hassan HM; Gao J; Gao J; Fan L; Liang X; Wang H; Ying S; Chen Q
J Proteome Res; 2023 Oct; 22(10):3200-3212. PubMed ID: 37624590
[TBL] [Abstract][Full Text] [Related]
25. MiR-221, a potential prognostic biomarker for recurrence in papillary thyroid cancer.
Dai L; Wang Y; Chen L; Zheng J; Li J; Wu X
World J Surg Oncol; 2017 Jan; 15(1):11. PubMed ID: 28061868
[TBL] [Abstract][Full Text] [Related]
26. Clinical and pathologic features of "sporadic" papillary thyroid carcinoma registered in the years 2005 to 2008 in children and adolescents of Belarus.
Fridman MV; Savva NN; Krasko OV; Zborovskaya AA; Mankovskaya SV; Schmid KW; Demidchik YE
Thyroid; 2012 Oct; 22(10):1016-24. PubMed ID: 22947350
[TBL] [Abstract][Full Text] [Related]
27. Non-invasive diagnosis of papillary thyroid microcarcinoma: a NMR-based metabolomics approach.
Lu J; Hu S; Miccoli P; Zeng Q; Liu S; Ran L; Hu C
Oncotarget; 2016 Dec; 7(49):81768-81777. PubMed ID: 27835583
[TBL] [Abstract][Full Text] [Related]
28. Expression of serum miR-218 in hepatocellular carcinoma and its prognostic significance.
Yang L; Xu Q; Xie H; Gu G; Jiang J
Clin Transl Oncol; 2016 Aug; 18(8):841-7. PubMed ID: 26586116
[TBL] [Abstract][Full Text] [Related]
29. Tumor abnormal protein as a promising biomarker for screening solid malignancies and monitoring recurrence and metastasis.
Zhang Z; Tian C; Liu Y; Zhang L; Sun H; He S; Liu Y; Fan H; Zhang Y; Gao M; Wu S
Front Oncol; 2023; 13():1290791. PubMed ID: 38115905
[TBL] [Abstract][Full Text] [Related]
30. Tumor abnormal protein (TAP) examination contributes to primary diagnosis of bladder cancer.
Zhang L; Guo X; Min Y; Xu J
Int J Clin Exp Med; 2015; 8(10):18528-32. PubMed ID: 26770464
[TBL] [Abstract][Full Text] [Related]
31. Podoplanin: An emerging cancer biomarker and therapeutic target.
Krishnan H; Rayes J; Miyashita T; Ishii G; Retzbach EP; Sheehan SA; Takemoto A; Chang YW; Yoneda K; Asai J; Jensen L; Chalise L; Natsume A; Goldberg GS
Cancer Sci; 2018 May; 109(5):1292-1299. PubMed ID: 29575529
[TBL] [Abstract][Full Text] [Related]
32. Prognostic Impact of Tumor Mutation Burden in Patients With Completely Resected Non-Small Cell Lung Cancer: Brief Report.
Owada-Ozaki Y; Muto S; Takagi H; Inoue T; Watanabe Y; Fukuhara M; Yamaura T; Okabe N; Matsumura Y; Hasegawa T; Ohsugi J; Hoshino M; Shio Y; Nanamiya H; Imai JI; Isogai T; Watanabe S; Suzuki H
J Thorac Oncol; 2018 Aug; 13(8):1217-1221. PubMed ID: 29654927
[TBL] [Abstract][Full Text] [Related]
33. Progress in the Management of Early-Stage Non-Small Cell Lung Cancer in 2017.
Donington JS; Kim YT; Tong B; Moreira AL; Bessich J; Weiss KD; Colson YL; Wigle D; Osarogiagbon RU; Zweig J; Wakelee H; Blasberg J; Daly M; Backhus L; Van Schil P
J Thorac Oncol; 2018 Jun; 13(6):767-778. PubMed ID: 29654928
[TBL] [Abstract][Full Text] [Related]
34. Chinese registry of rheumatoid arthritis (CREDIT): I. Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis.
Yu C; Li M; Duan X; Fang Y; Li Q; Wu R; Liu S; Wang Y; Wu Z; Shi X; Jiang Z; Wang Y; Hsieh ED; Jin S; Jiang N; Wang Q; Zhao Y; Tian X; Zeng X;
Clin Exp Rheumatol; 2018; 36(5):836-840. PubMed ID: 29600939
[TBL] [Abstract][Full Text] [Related]
35. Anti-epidermal growth factor receptor therapy concurrently with induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
Peng H; Tang LL; Liu X; Chen L; Li WF; Mao YP; Zhang Y; Liu LZ; Tian L; Guo Y; Sun Y; Ma J
Cancer Sci; 2018 May; 109(5):1609-1616. PubMed ID: 29575438
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive analysis of differential expression profiles of mRNAs and lncRNAs and identification of a 14-lncRNA prognostic signature for patients with colon adenocarcinoma.
Xing Y; Zhao Z; Zhu Y; Zhao L; Zhu A; Piao D
Oncol Rep; 2018 May; 39(5):2365-2375. PubMed ID: 29565464
[TBL] [Abstract][Full Text] [Related]
37. Dual expression of CXCR4 and IL-35 enhances the therapeutic effects of BMSCs on TNBS-induced colitis in rats through expansion of Tregs and suppression of Th17 cells.
Nan Z; Fan H; Tang Q; Zhang M; Xu M; Chen Q; Liu Y; Dong Y; Wu H; Deng S
Biochem Biophys Res Commun; 2018 May; 499(4):727-734. PubMed ID: 29524405
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
